Identification of factors associated with aggressive end-of-life antitumour treatment: retrospective study of 1282 patients with cancer.

Philippe Debourdeau,Mohamed Belkacémi,Guillaume Economos,Eric Assénat,Werner Hilgers,Julie Coussirou,Sfaya Kouidri Uzan,Léa Vasquez,Antoine Debourdeau,Jean Pierre Daures,Sebastien Salas

BMJ supportive & palliative care（2020）

引用 0|浏览13

暂无评分

摘要

Most recent ATT and access to a PCT follow-up are the two most important potentially modifiable factors associated with aggressive EOL in patients with cancer. Early integrated palliative oncology care could help to decrease futile ATT at EOL.

查看译文

关键词

Cancer,End-of-life care

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要